Kerr Drugs

As noted earlier, the mission statement creates a sense of purpose for both the employees and customers of the organization. Employees of Kerr Drug know that their customers will expect reliable and comprehensive services and therefore that they should strive to provide that each day. This chapter later discusses how pharmacies such as Kerr Drug that have well-defined missions and that engage in strategic planning are more likely to be successful. 

Daniels, J., Nestmann, E., and Kerr, A. (1997). Development of stereoisomeric (chiral) drugs A brief review of the scientific and regulatory considerations. Drug Information J. 639-646. 

S. W. Martin, F. E. Bishop, B. M. Kerr, M. Moor, M. Moore, P. Sheffels, M. Rashed, J. G. Slatter, L. Berthon-Cedille, F. Lepage, J.-J. Descombe, M. Picard, T. A. Baillie, R. H. Levy, Pharmacokinetics and Metabolism of the Novel Anticonvulsant Agent N-(2,6-Dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in Rats and Humans , Drug Metab. Dispos. 1997, 25, 40-46. 

Eliopoulos AG, Kerr DJ, Herod J, et al. The control of apoptosis and drug resistance in ovarian cancer influence of p53 and Bcl-2. Oncogene 1995 11 1217-1228. 

J. M. Daniels, E. R. Nestmann, A. Kerr (1997). Development of stereoisomeric drugs a brief review of scientific and regulatory considerations. Drug Inf. J. 31 639. 

Kerr, J. S., Slee, A. M., and Mousa, S. A. Small molecule alpha(v) integrin antagonists Novel anticancer agents. Exp. Opin. Invest. Drugs 9 1271-1279, 2000. 

Tran JQ, Gerber JG, Kerr BM. Delavirdine clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 2001 40 207-226. 

Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O (2000) Control of cocainseeking behavior by drug-associated stimuli in rats effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA 97 4321-6. 

Weiss F, Martin-Fardon R, Ciccocioppo R, Kerr TM, Smith DL, Ben-Shahar O (2001) Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues. Neuropsychopharmacology 25(3) 361-372. 

The LeFevres departed for the University of Sydney in 1946, and there, in addition to continuing research on the Kerr effect, Tideman developed broader interests. She became involved with social issues, particularly drug dependency and the drug problem in New South Wales. Later, she became involved in forensic science issues, becoming the first woman elected to the Council of the Australian Academy of Forensic Sciences.47 She was also heavily involved in programmes to encourage women into science. Tideman died in Sydney on 9 March 1998. 

Graham MA, Riley RJ, Kerr DJ. Drug metabolism in carcinogenesis and cancer chemotherapy. Pharmacol Ther 1991 51 275-89. 

Sturchler D, Mittelholzer ML, Kerr L. How frequent are notified severe cutaneous adverse reactions to Fansidar Drug Saf 1993 8(2) 160-8. 

Lillibridge JH, Liang BH, Kerr BM, et al. Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. Drug Metab Disp. 1998 26 609-616. 

Kerr TA+, Acta Psychiatr Scand 70(6), 573 (1982) Rawls WN, Drug Intell Clin Pharm 16, 7... 

Krenzelok EP> Kerr F, Proudfoot AT. Salicylate toxicity. In Haddad LM, Shannon MW, Winchester JF, eds. Clinical management of poisoning and drug over-... 

M. H. Zhang, Y. K. Pithavala, C. A. Lee, J. H. Lillibridge, E. Y. Wu, T. M. Sandoval, R. G. Daniels, and B. M. Kerr, Apparent genetic polymorphism in nelflnavir metabolism evaluation of clinical relevance. Proceedings of the 12th International Symposium of Microsomes and Drug Oxidations, Montpellier, France, July 20-24, 1998, abstract 264. 

Gillet VJ (2004) Applications of Evolutionary Computation in Drug Design 110 133-152 Gin DL, Pecinovsky CS, Bara JE, Kerr RL (2008) Functional Lyotropic Liquid Crystal Materials. 128 181-222... 

Clark, R. C., Maxwell, S. R, Kerr, S., Cuthbert, M., Buchanan, D., Steinke, D., et al. (2007). The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions. Drug Safety An International Journal of Medical Toxicology and Drug Experience, 30(4), 357-366. 

Dixon, C.M. Colthup, P.V. Serabjit-Singh, C.J. Kerr, B.M. Boehlert, C.C. Park, G.R. Tarbit, M.H. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. Drug Metab.Dispos., 1995,23, 1225-1230... 

Z2. Zucker, S., Cao, J., and Molloy, C. J., Role of matrix metalloproteinases and plasminogen activators in cancer and metastasis Therapeutic strategies. In Anticancer Drug Development (B. C Baguley and D. J. Kerr, eds.), pp. 91-122. Academic Press, San Diego, CA, 2002. 

Seymour LW, Ferry DR, Anderson D, Hesslewood S, Julyan PJ, Payner R, Doran J, Young AM, Burtles S, Kerr DJ. Hepatic drug targeting phase I evaluation of polymer bound doxorubicin. J Clin Oncol 2002 20 1668-1676. 

Kerr B, Yuep G, Daniels R, Quart B, Kravcik S, Sahai J, Anderson R. Strategic approach to nelflnavir mesylate (NFV) drug interactions involving CYP3A metabolism. 6 European Conference on Clinical Aspects and Treatment of HIV-infection, Hamburg, October 11-15 1997. Abstracts. 

Murray LS, Jodrell DI, Morrison JG, Cook A, Kerr DJ, Whiting B, Kaye SB, Cassidy J. The effect of cimetidine on die pharmacokinetics of epirubicin in patients widi advanced breast cancer preliminary evidence of a potentially common drug interaction. Clin Oncol( 99Z) 10,... 

Cox SR, Schneck DW, Herman BD, Carel BJ, Gulloth BR, Kerr BM, Freimuth WW. Delavirdine (DLV) and nelfinavir (NFV) A pharmacokinetic (PK) drug-drug interaction study in healthy adult volunteers. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, 1998. Abstract 345. 

Kerr B, Lee C, Yuen G, Anderson R, Daniels R, Grettenbeiger H, Liai B-H, Qu B, Sandoval T, Shetly B, Wu E, 2hang K. Overview of in-vitro and in-vivo drug interaction studies ofrielfiiiavirme late(NFy), anew HIV-1 protease inhibitor. 4 Conference on Retroviruses and Opportunistic Infections, WashingtonDC, 1997. Session 39, Slide 373. 

---